Activation of protein kinase C in human hepatocellular carcinoma (HEP3B) cells increases erythropoietin production
Authors:
- Sanda ClejanSCSanda Clejan
- James W. FisherJFJames W. Fisher
- 1 July 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 63 (7) , 523-535
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nitric oxide enhancement of erythropoietin production in the isolated perfused rat kidneyAmerican Journal of Physiology-Cell Physiology, 1995
- Distinct Signaling Pathways Mediate Phorbol‐Ester‐Induced and Cytokine‐Induced Inhibition of Erythropoietin Gene ExpressionEuropean Journal of Biochemistry, 1994
- In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reactionBlood, 1993
- Phorbol ester inhibits erythropoietin production in human hepatoma cells (Hep G2)American Journal of Physiology-Cell Physiology, 1992
- Chelerythrine is a potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1990
- Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietinKidney International, 1990
- Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposureBlood, 1989
- Inhibitory effects of tetradecanoylphorbol acetate and diacylglycerol on erythropoietin production in human renal carcinoma cell culturesExperimental Cell Research, 1987
- Physiologic regulation and tissue localization of renal erythropoietin messenger RNABlood, 1987
- N-(6-Phenylhexyl)-5-chloro-1-naphthalenesulfonamide is one of a new class of activators for Ca2+-activated, phospholipid-dependent protein kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986